Short and long-term acceptability and efficacy of extended-release cornstarch in the hepatic glycogen storage diseases: results from the Glyde study.

Fewer doses of therapy were required per day during the longitudinal part of the study for participants treated with Glycosade (Table 3 a and 3 b) compared with UCCS although this did not reach statistical significance.

also in 111,027 other papers